Panavance Therapeutics Inc. is a US, clinical-stage pharmaceutical company established in 2021 by the Swiss-based Avensis Pharma AG, a subsidiary of Ed. Geistlich Söhne AG für Chemische Industrie. Panavance is focused on advancing the development of GP-2250, a novel oncology therapeutic intended to improve outcomes and quality of life for patients with cancer. With its highly capable team and strong academic and industry partnerships, Panavance is pursuing a rigorous program to bring GP-2250 to patients around the world.
View Top Employees from Panavance Therapeutics Inc.| Website | http://www.panavance.com |
| Employees | 9 (4 on RocketReach) |
| Founded | 2021 |
| Address | 1055 Westlakes Dr Suite 300, Berwyn, Pennsylvania 19312, US |
| Industry | Pharmaceutical Manufacturing |
Looking for a particular Panavance Therapeutics Inc. employee's phone or email?
Panavance Therapeutics Inc. Questions
4 people are employed at Panavance Therapeutics Inc..
Panavance Therapeutics Inc. is based in Berwyn, Pennsylvania.
Top Panavance Therapeutics Inc. Employees
-
5+5+
-
5+
-
32
Related Companies
